Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)

Br J Haematol. 2019 Jul;186(1):146-149. doi: 10.1111/bjh.15718. Epub 2018 Dec 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bendamustine Hydrochloride / therapeutic use
  • Female
  • Humans
  • Lymphoproliferative Disorders / drug therapy
  • Male
  • Middle Aged
  • Rituximab / therapeutic use
  • Waldenstrom Macroglobulinemia / drug therapy*

Substances

  • Rituximab
  • Bendamustine Hydrochloride